CBD Products & CBD Business News

Sol Global increases ownership stake in CBD firm HeavenlyRx

Cannabis investment company Sol Global Investments purchased additional common shares to raise its ownership in its CBD-focused wellness subsidiary HeavenlyRx to 44.53%. As part of a larger private offering, the Toronto-based international investment company announced Monday it spent an additional 23.9 million Canadian dollars ($18.1 million) on HeavenlyRx. The announcement comes just weeks after Sol […]

Read More

Curaleaf scrubs website for medical claims following FDA warning

After federal regulators warned cannabis giant Curaleaf last week against making unsubstantiated medical claims for its CBD products, the company has taken action. The Massachusetts cannabis company removed its blog and deleted social media posts and articles on its website saying its products can be used to treat medical conditions such as cancer, Alzheimer’s disease, chronic […]

Read More

European Medicines Agency panel OKs GW Pharma’s cannabis drug

The Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex, said the drug’s maker, GW Pharmaceuticals. The CHMP is tasked with preparing the European Medicines Agency’s opinions on queries about the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now […]

Read More

‘Imperative to have mainstream experience’ in the growing CBD sector: Q&A with HeavenlyRx CEO Paul Norman

As hemp and CBD companies increasingly lure executive-level talent away from mainstream corporations, many are coming from large food companies. The Kellogg Co. is one of them. The $13 billion food giant recently saw three of its executives leave for positions in the cannabis space, including Paul Norman, a former president of Kellogg North America, […]

Read More

Canadian CBD maker sponsors athlete research with UFC

Canadian marijuana giant Aurora Cannabis is sponsoring CBD research with the UFC to determine if the cannabinoid treatments are effective in treating pain and inflammation. The partnership marks a milestone for the cannabis industry, where individual athletes commonly strike sponsorship deals but few prominent leagues agree to research for CBD or other cannabis products. Athletes’ […]

Read More

California CBD company buys chocolate-maker with national distribution

A California CBD company that makes infused olive oils has bought a smaller chocolate company with distribution in traditional grocers such as Whole Foods Market. Gabriella’s Kitchen bought Lulu’s Chocolates of Nevada City, California, for $1 million in stock. Margot Micallef, CEO of Gabriella’s Kitchen, told Hemp Industry Daily the acquisition positions her company for distribution […]

Read More

Ex-US surgeon general joins CBD company’s advisory board

A former U.S. surgeon general is joining the advisory board of a California CBD company. Dr. Richard Carmona, who served as surgeon general from 2002 to 2008, will advise Kadenwood, a privately held company that makes topical CBD products in Newport Beach, California. The appointment gives Kadenwood a government insider to “shift the perception of […]

Read More

Hemp, CBD companies lining up university research to validate anecdotal evidence

A surge in academic research about hemp-derived cannabinoids is giving CBD companies new opportunities to find university partners to validate mountains of anecdotal evidence about cannabidiol’s health benefits. The research boom is enabled by hemp’s new legal status and funded by cannabis entrepreneurs who see an opportunity to bring a stamp of authority to an […]

Read More

Canadian acquisition underscores CBD’s potential in Europe

A Canadian marijuana producer cited hemp and CBD’s potential in Europe as it announced plans to acquire a smaller Canadian company with a CBD subsidiary in the Netherlands. The announcement Wednesday that Toronto-based Supreme Cannabis plans to acquire Truverra underscores the interest in accessing European markets. Supreme valued the acquisition at roughly $20 million. Supreme […]

Read More

Pictures, please! Hemp group wants more evidence to fight European CBD limit

European hemp producers and manufacturers are getting renewed pleas to help fight the European Union on how it treats CBD and other extracts. The European Industrial Hemp Association (EIHA) sent an alert this week to roughly 300 members urging the EU to change its Common Agricultural Policy, which governs food rules, according to Hemp Today. The […]

Read More

Here’s final chance to tell FDA how it should regulate CBD

U.S. health authorities are taking final comments from the public on how to regulate over-the-counter cannabis extracts such as CBD. The suggestions are due to the U.S. Food and Drug Administration (FDA) by midnight ET Tuesday, July 16, on how the agency should regulate cannabis-derived products. The FDA has vowed to expedite its review of cannabis-derived compounds […]

Read More